BioAtla to Announce First Quarter 2024 Financial Results and Provide Business Highlights on May 14, 2024
May 07, 2024 08:00 ET
|
BioAtla, Inc.
SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody...
Corbus Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 07, 2024 08:00 ET
|
Corbus Pharmaceuticals Holdings, Inc.
Phase 1 data for CRB-701 (SYS6002) to be presented at ASCO Annual Meeting on June 1, 2024 $116M of capital raised in Q1 2024 extending cash runway through Q1 2027 Appointed Dr. Dominic...
Talkspace Announces First Quarter 2024 Results
May 07, 2024 08:00 ET
|
Talkspace
1Q 2024 Total revenue grew 36% year-over-year 1Q 2024 Payor revenue grew 92% year-over-year Reduced GAAP Net loss to $1.5 million from $8.8 million year-over-year Delivers...
Cogent Biosciences Reports First Quarter 2024 Financial Results
May 07, 2024 08:00 ET
|
Cogent Biosciences, Inc.
SUMMIT, PEAK and APEX registration-directed clinical trial enrollment remains on track; topline results expected from all three studies in 2025 Ended 1Q 2024 with $435.7 million in cash, sufficient...
Phunware Appoints Hospitality Industry Veteran as Strategic Advisor to Propel Hospitality Sector Growth
May 07, 2024 08:00 ET
|
Phunware, Inc.
AUSTIN, Texas, May 07, 2024 (GLOBE NEWSWIRE) -- Phunware, Inc. (NASDAQ: PHUN) (the “Company”), the leading provider of patented wayfinding and mobile engagement solutions that enable brands to...
Sales and Profitability Growth Drive Continuing Momentum in L.B. Foster First Quarter 2024 Results; Company Reaffirms 2024 Guidance
May 07, 2024 08:00 ET
|
L.B. Foster Company
First quarter net sales of $124.3 million up 7.6% year over year (up 16.9% organically1); gross profit of $26.2 million up 12.7% year over year with gross margins expanding 90 basis points ("bps") to...
PDS Biotech to Announce First Quarter 2024 Financial Results on May 15, 2024
May 07, 2024 08:00 ET
|
PDS Biotechnology Corporation
PRINCETON, N.J., May 07, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the...
VPN Risk Report Finds More Than Half of Organizations Experienced a VPN-related Cyberattack in the Last Year
May 07, 2024 08:00 ET
|
Zscaler, Inc.
VPN security concerns rise as 91% of respondents express concerns about VPNs leading to a compromising breachThe survey identifies the top threats exploiting VPN vulnerabilities to be ransomware...
INmune Bio Inc. to Report First Quarter 2024 Financial Results and Provide a Corporate Update on Thursday, May 9
May 07, 2024 08:00 ET
|
INmune Bio, Inc.
Management to host conference call and webcast at 4:30 pm ET on that day Boca Raton, Florida, May 07, 2024 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage...
Biora Therapeutics to Report First Quarter 2024 Financial Results and Provide Corporate Update
May 07, 2024 08:00 ET
|
Biora Therapeutics, Inc.
The company’s management will host a webcast and conference call on Wednesday, May 15, 2024, after the close of financial markets.